AURKB and breast carcinoma: As revealed in our previous experiment, there was no significant difference in the relative expression of AURKB in breast cancer cells (MDA-MB-231 and BT549) and the corresponding PTX-resistant cells (MDA-MB-231/PTX and BT549/PTX).